UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

Risk management and healthcare policy, 2018-01, Vol.11, p.109-116

2018

Volltextzugriff (PDF)

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Clinical drug investigation, 2017-08, Vol.37 (8), p.763-773

2017

Volltextzugriff (PDF)

Remifentanil, Fentanyl, or the Combination in Surgical Procedures in the United States: Predictors of Use in Patients with Organ Impairment or Obesity

Clinical drug investigation, 2015-01, Vol.35 (1), p.53-59

Sclar, David Alexander

2015

Volltextzugriff (PDF)

Quantifying Gabapentin Misuse With Opioids

Primary care companion for CNS disorders, 2019-03, Vol.21 (2)

2019

Volltextzugriff (PDF)

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Therapeutics and clinical risk management, 2017-01, Vol.13, p.957-965

2017

Volltextzugriff (PDF)

Bioequivalence evaluation of epinephrine autoinjectors with attention to rapid delivery

Therapeutics and clinical risk management, 2013-01, Vol.9 (default), p.149-151

Sclar, David Alexander

2013

Volltextzugriff (PDF)

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

Drug, healthcare and patient safety, 2018-01, Vol.10, p.37-43

2018

Volltextzugriff (PDF)

Beyond Stereotypes: American Jews and Sports

Sclar, Ari F

1, 2015

Volltextzugriff (PDF)

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

International clinical psychopharmacology, 2008-03, Vol.23 (2), p.106

2008

Volltextzugriff (PDF)

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995

Clinical pediatrics, 1999-04, Vol.38 (4), p.209-217

1999

Volltextzugriff (PDF)

Breast cancer mortality declining but screening among subpopulations lags

American journal of public health (1971), 1998-02, Vol.88 (2), p.307-308

1998

Volltextzugriff (PDF)

Trends in ADHD and stimulant use among adults: 1995-2002

Psychiatric services (Washington, D.C.), 2005-12, Vol.56 (12)

2005

Volltextzugriff (PDF)

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992–1997

Clinical therapeutics, 2000-12, Vol.22 (12), p.1575-1589

2000

Volltextzugriff (PDF)

PMH80 THE ASSOCIATION BETWEEN TYPE OF ANTIPSYCHOTIC AND RATES OF HOSPITALIZATION AMONG MEDICARE BENEFICIARIES

Value in health, 2010, Vol.13 (3), p.A119-A119

2010

Volltextzugriff (PDF)

The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population

Medical care, 1994-03, Vol.32 (3), p.214-226

1994

Volltextzugriff (PDF)

Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada

Journal of clinical pharmacy and therapeutics, 2002-06, Vol.27 (3), p.213-220

2002

Volltextzugriff (PDF)

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99

International clinical psychopharmacology, 2004-01, Vol.19 (1), p.17-22

2004

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1998-11, Vol.20 (6), p.1192-1193

Sclar, David Alexander

1998

Volltextzugriff (PDF)

Pharmaceutical economics & health policy : Editorial comment

Clinical therapeutics, 1996-09, Vol.18 (5), p.876-876

Sclar, DavidAlexander

1996

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1998, Vol.20 (1), p.158-159

Sclar, David Alexander

1998

Volltextzugriff (PDF)

Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization

Clinical therapeutics, 1994-07, Vol.16 (4), p.715-30; discussion 74

1994

Volltextzugriff (PDF)

Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995

Harvard review of psychiatry, 1999-05, Vol.7 (1), p.29-36

1999

Volltextzugriff (PDF)

Pharmaceutical economics & health policy : Editorial comment

Clinical therapeutics, 1996-05, Vol.18 (3), p.520-520

Sclar, DavidAlexander

1996

Volltextzugriff (PDF)

Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990–1995

Clinical therapeutics, 1998-07, Vol.20 (4), p.871-884

1998

Volltextzugriff (PDF)

Pharmaceutical economics & health policy: Editorial comment

Clinical therapeutics, 1997-09, Vol.19 (5), p.1068-1069

Sclar, David Alexander

1997

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(87)
Bücher
(1)

Sprache

Englisch
(88)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(81)
Science & Technology
(81)
Pharmacology & Pharmacy
(59)
Humans
(51)
Biological And Medical Sciences
(40)
Female
(39)
Medical Sciences
(39)
Male
(37)
Middle Aged
(33)
Pharmacology. Drug Treatments
(33)
Adult
(29)
Aged
(21)
United States
(15)
Health Care Sciences & Services
(12)
Medicine, Research & Experimental
(12)
Neuropharmacology
(12)
Psychology. Psychoanalysis. Psychiatry
(12)
Research & Experimental Medicine
(12)
Patient Compliance
(11)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Remifentanil, Fentanyl, or the Combination in Surgical Procedures in the United States: Predictors of Use in Patients with Organ Impairment or Obesity

Quantifying Gabapentin Misuse With Opioids

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Bioequivalence evaluation of epinephrine autoinjectors with attention to rapid delivery

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

Beyond Stereotypes: American Jews and Sports

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995

Breast cancer mortality declining but screening among subpopulations lags

Trends in ADHD and stimulant use among adults: 1995-2002

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992–1997

PMH80 THE ASSOCIATION BETWEEN TYPE OF ANTIPSYCHOTIC AND RATES OF HOSPITALIZATION AMONG MEDICARE BENEFICIARIES

The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population

Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99

Pharmaceutical economics & health policy: Editorial comment

Pharmaceutical economics & health policy : Editorial comment

Pharmaceutical economics & health policy: Editorial comment

Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization

Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995

Pharmaceutical economics & health policy : Editorial comment

Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990–1995

Pharmaceutical economics & health policy: Editorial comment

Suchergebnisse filtern